Updates are available Correction dated 2023-08-11
Click to view Correction: https://doi.org/10.1038/s41556-023-01220-x
-
Authors
Papsdorf, Katharina
Miklas, Jason W. https://orcid.org/0000-0002-9002-0667
Hosseini, Amir
Cabruja, Matias
Morrow, Christopher S.
Savini, Marzia
Yu, Yong
Silva-García, Carlos G. https://orcid.org/0000-0002-0434-7787
Haseley, Nicole R.
Murphy, Luke Meraz
Yao, Pallas
de Launoit, Elisa
Dixon, Scott J. https://orcid.org/0000-0001-6230-8199
Snyder, Michael P. https://orcid.org/0000-0003-0784-7987
Wang, Meng C. https://orcid.org/0000-0002-5898-6007
Mair, William B. https://orcid.org/0000-0002-0661-1342
Brunet, Anne https://orcid.org/0000-0002-4608-6845
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG054201, R01AG054201, R01AG054201, R01AG054201, R01AG054201, R01AG054201, R01AG054201, R01AG054201, R01AG054201, R01AG054201, R01AG054201)
Larry L. Hillblom Foundation
- License Information
-
More Information
Article History
Received: 20 December 2022
Accepted: 23 March 2023
First Online: 1 May 2023
Change Date: 11 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41556-023-01220-x
Competing interests
: A.B. is a scientific advisor of Calico. M.P.S. is a co-founder and scientific advisor of Personalis, SensOmics, Qbio, January AI, Fodsel, Filtricine, Protos, RTHM, Iollo, Marble Therapeutics, Crosshair Therapeutics and Mirvie. He is a scientific advisor of Jupiter, Neuvivo, Swaza and Mitrix. S.J.D. is a co-founder of Prothegen Inc, a scientific advisor of Hillstream BioPharma and holds patents related to ferroptosis. All other authors declare no competing interests.
